Skip to main content

NEUBERGER BERMAN GROUP LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1465109 NEW YORK, NY

Position in BMRN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$926,735
-$1,189,887 QoQ
Shares Held
16,196
-56.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#285
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 32% Shared 0% None 68%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Mar 31, 2025
CallValue
$204,930
CallShares
2,899
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NEUBERGER BERMAN GROUP LLC holds $1,452,567,393 across 97 Biotechnology names. BMRN ranks #40 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BMRN

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $926,735 16,196
2026-03-31 $2,116,622 37,469
2025-12-31 $2,205,862 37,117
2025-09-30 $1,612,451 29,772
2025-06-30 $1,745,681 31,757
2025-03-31 $6,798,045 96,167
2025-03-31 $204,930 2,899
2024-12-31 $6,162,318 93,752
2024-12-31 $146,183 2,224
2024-09-30 $63,090,827 897,579
2024-09-30 $80,411 1,144
2024-06-30 $90,084,909 1,094,193
2024-03-31 $40,676,857 465,730
2024-03-31 $63,059 722
2023-12-31 $33,623,774 348,722
2023-09-30 $21,290,764 240,628
2023-06-30 $17,387,660 200,596
2023-03-31 $14,979,529 154,047
2022-12-31 $17,492,086 169,022
2022-09-30 $14,142,771 166,837
2022-06-30 $2,277,350 27,481
2022-03-31 $2,137,443 27,723
2021-12-31 $2,887,895 32,687
2021-09-30 $2,105,765 27,245
2021-06-30 $2,722,730 32,631
2021-03-31 $2,809,046 37,201
2020-12-31 $3,140,178 35,810
2020-09-30 $5,932,794 77,981
2020-06-30 $10,523,984 85,325
2020-03-31 $17,196,764 203,512